Adherence to cardiovascular medications: lessons learned and future directions.
about
Adherence to Antihypertensive Therapy.Persistence of antihypertensive drug use in German primary care: a follow-up study based on pharmacy claims data.Phases in development of an interactive mobile phone-based system to support self-management of hypertension.Anxiety sensitivity and medication nonadherence in patients with uncontrolled hypertension.Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience.Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.Supporting the self-management of hypertension: Patients' experiences of using a mobile phone-based systemAdherence and health care costs.Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy.Secondary prevention and cognitive function after stroke: a study protocol for a 5-year follow-up of the ASPIRE-S cohortIntentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study.The development of the ProMAS: a Probabilistic Medication Adherence ScaleDisparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence.Cognitive impairment and cardiovascular medication use: Results from Wave 1 of The Irish Longitudinal Study on Ageing.Does Health Information in Mass Media Help or Hurt Patients? Investigation of Potential Negative Influence of Mass Media Health Information on Patients' Beliefs and Medication Regimen Adherence.Antihypertensive Adherence Trajectories Among Older Adults in the First Year After Initiation of Therapy.Medication adherence among cardiac patients in Khartoum State, Sudan: a cross-sectional study.Does Stress Result in You Exercising Less? Or Does Exercising Result in You Being Less Stressed? Or Is It Both? Testing the Bi-directional Stress-Exercise Association at the Group and Person (N of 1) Level.Medical expulsive therapy for ureteral stones: where do we go from here?Anxiety Disorders and Cardiovascular Disease.Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.Incorporating Patients' Social Determinants of Health into Hypertension and Depression Care: A Pilot Randomized Controlled Trial.Medication Adherence Improvement By Using Administration Timing Simplification Protocol (ATSP) in Cardiovascular Disease Patients.Hypertensive Urgencies: The Epidemic, Causes, and Consequences.Patient perceptions of stress during evaluation for ACS in the ED.Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke.Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?Effect of characteristics of pharmacotherapy on non-adherence in chronic cardiovascular disease: A systematic review and meta-analysis of observational studies.Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice.Evaluating practical support stroke survivors get with medicines and unmet needs in primary care: a survey.Health inequalities in secondary prevention.Implications of prescribing a fixed-dose combination in clinical cardiology practice: a retrospective observational study using a single medical centre database in Korea.Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts.Nonadherence to statins: individualized intervention strategies outside the pill box.Association of functional and structural social support with medication adherence among individuals treated for coronary heart disease risk factors: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World PracticeStress, adherence, and blood pressure control: A baseline examination of Black women with hypertension participating in the SisterTalk II interventionThe Use of Dried Blood Spots for the Quantification of Antihypertensive Drugs
P2860
Q30240726-5F49C64D-D379-4416-A5AA-7C6B2423B197Q30701410-450D2904-C11D-4EEB-9C53-C50E02E89E09Q33715041-BB4ECF8E-F7D3-425B-A3FD-509F2CDF0391Q34289558-1A179D02-8C99-49D5-B1FF-10479509C61EQ36113704-4A2FCD7D-653E-490C-86BA-D0D28799A9CBQ36284450-17877921-A3E3-4C1A-80C7-6AA2C34D1790Q36442481-C0B56506-12B7-46A9-A78C-64B8CBED3755Q37603117-CD7E7358-8048-4F98-A309-02FB7D30D39DQ37630784-964837C8-7D60-4A8F-9F9A-28622AEBF50BQ37728288-CAB14C0F-271B-4A45-B47C-8E6165722895Q37733137-30D51A25-1FB7-4FC7-9191-75F3BCAC9C4DQ38444862-71594C59-8FE7-480A-B54E-EBD952C0D696Q38600825-0548F47E-8781-45E4-A856-3C9270D90F58Q38610602-7829F688-18EB-47E1-8066-97634266E00DQ38751966-F601EEB8-96E8-42D9-8088-6DF83AF56BE3Q38768882-6C8C2F3B-4B4F-4D11-AEA1-C15510D35F0CQ38874465-C1BD9967-2CA5-47E8-8A66-A87F21A35D67Q38909940-1666522A-D824-4F7C-A614-8F64E97A6FAAQ38915397-607A0D39-559D-4B47-90C8-CDC176A54EBDQ38965295-4811CBD5-85F7-41C5-A362-7FBA55AE5124Q39105190-3A58921F-6E69-4D54-96AC-384146EBC866Q40257634-10585B1C-322A-474A-AA47-8931A0F74D2EQ41389916-73F157A6-753A-4DE3-839E-DCDBC11D87AEQ42053496-7523465D-F31F-4BD7-B2F9-547C833FA69BQ47096505-2CC37416-503D-418C-A081-7D3D047CB4CFQ47137885-B333711C-459C-4AA0-83CB-64B850305292Q47927743-D8183AC6-8A51-478C-B8BE-351E59294635Q48200253-C20554A3-F580-4180-BE36-ED67925ECF36Q48508504-5D694392-3E5F-47BE-864D-13F4F24435BAQ52661894-46B30A49-B486-4A55-8573-16E9436E41A5Q52838035-E3C18B72-AD0D-4889-8721-5E97C2224D7CQ53082193-5EBE87D6-2DDD-4D19-9B4E-CB7A94101E43Q54941647-B4908651-8D5D-4879-AE22-1A24AD3A6F4DQ55011566-92EAC52D-96D9-4CFE-887C-8F7A7843C7FEQ55501501-16AF35A8-F88D-4522-A181-DA98CE71B17FQ58784311-BA28D91E-DF61-42B8-981C-333A001EDED4Q58801176-A2030382-EEF8-46CA-908D-C0BD0E91A8A5Q58805777-FE4AA254-3A94-478E-9552-C08BD9038A36
P2860
Adherence to cardiovascular medications: lessons learned and future directions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Adherence to cardiovascular medications: lessons learned and future directions.
@ast
Adherence to cardiovascular medications: lessons learned and future directions.
@en
type
label
Adherence to cardiovascular medications: lessons learned and future directions.
@ast
Adherence to cardiovascular medications: lessons learned and future directions.
@en
prefLabel
Adherence to cardiovascular medications: lessons learned and future directions.
@ast
Adherence to cardiovascular medications: lessons learned and future directions.
@en
P2860
P1476
Adherence to cardiovascular medications: lessons learned and future directions.
@en
P2093
Ian M Kronish
P2860
P304
P356
10.1016/J.PCAD.2013.02.001
P577
2013-03-23T00:00:00Z